Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx

上传人:p** 文档编号:1058819 上传时间:2024-06-29 格式:DOCX 页数:13 大小:27.90KB
下载 相关 举报
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第1页
第1页 / 共13页
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第2页
第2页 / 共13页
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第3页
第3页 / 共13页
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第4页
第4页 / 共13页
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第5页
第5页 / 共13页
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第6页
第6页 / 共13页
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第7页
第7页 / 共13页
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第8页
第8页 / 共13页
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第9页
第9页 / 共13页
Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx_第10页
第10页 / 共13页
亲,该文档总共13页,到这儿已超出免费预览范围,如果喜欢就下载吧!
资源描述

《Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx》由会员分享,可在线阅读,更多相关《Marketing strategies of GMP syndrome(GMP综合症的营销对策).docx(13页珍藏版)》请在第壹文秘上搜索。

1、MarketingstrategiesofGMPsyndrome(GMP综合症的营销对策)MarketingstrategiesofGMBsyndrome(GMP综合症的营销对策)AccordingtotherelevantdepartmentsofSFDAstatistics,beforeJuly1st,throughtheGMPcertificationofpharmaceuticalenterprisesinabout3100,accountingfor60%ofthecountry.Thereare2000enterprises,nearly900workshopswereforced

2、tostopproduction.EnterprisesthathavepassedGMPaccountfor90%ofthedomesticpharmaceuticalmarket,andthedrugscoveral1thecommonlyusedclinicalproducts,whichcancompletelymeetthemarketdemand.Thereisasayingintheindustry:butGMPGMPisdead,too!Infact,GMPisnotanadministrativetypeofdeathlaw;theimplementationofGMPisa

3、neconomictypeofdeath.ButtherewaslittlenewsornewsthataroundanumberofsmallandmediumenterprisestoabandonGMPcertificationinJuly1staftertheclimaxcontinued,issaidbyGMBtoreducetherepeatedlowleveloftheoriginalbuildingislost!However,smallandmedium-sizedpharmaceuticalcompanieshavepassedthenationalGMPcertifica

4、tion,butitisdifficulttoberecognizedbythemarket,generallysufferingfromGMPsyndrome,thefollowingauthoronthisissue,talkabouttheirownthinkingandcountermeasures.Oneofthesymptoms,operatingcostssubstantialIyimproved1,thecostofimprovingtheclinicalperformance(1)thecostofpassingGMPisprohibitive11isunderstoodth

5、atGMPhasmorethan80certificationrules,includingmorethan200inspectioniternsetc.druglabelsandinstructionsforuse,ordrug,involvesmanyaspectsofsoftwareandhardware,managementcontent,theimplementationofGMPisacomplicatedandhugesystemengineering.Accordingtopublicinformation,on1ythetransformationofafactory,ent

6、erprisesspendlessthantheamountofmillionsoffunds,morethantensofmillionsofdegrees.AccordingtothesurveyresearchcenterChinasocialeconomicsurveyinconjunctionWithrelevantassociationsChinapharmaceuticalenterprisecompetitivenessresearchgroupinSichuan,anareaofatotalof21pharmaceuticalcompanies,fixedassetsof1.

7、8million,totalinvestmentandthetransformationofGMP5companiesis220millionyuan.Theannualoutputvalueofanenterpriseisonly10millionyuan,thescientificresearchstrengthisveryweak,only30varietiesandtheproductionofgenericdrugstomaintain,financing50millionyuanthroughtheGMPcertification,howtomaketheequipmentidle

8、,whatproductionvarieties,hasbecometheproblem:seeingloanmaturity,whilethesalesamountisstagnating,lettheenterpriseresponsibleforpeoplescorchedbytheflames.Xi,anpharmaceutical1imited1iabi1itycompanyspent35mi11ionyuanrenovationoftraditionalChinesemedicinepreparationworkshopandpassedtheGMPcertification,th

9、eannualproductioncapacityof50millionyuanincreasedtonearlybillionyuan,butbecauseoperatingcostsincreasedby20times,thepressureascanbeimagined.(2)theoperationcosthasbeengreatlyimprovedAIlcompanieshavesomeGMPafterincreasedoperationalcosts,theauthorheardenterprisemadeinthegovernmentheldameetingtosolvereal

10、businessproblems:thegovernmentwillallowustomovebacktothenonGMPworkshopproductionoftheoriginaljoke.Thehighoperatingcostsaremanifestedinthefollowingaspects:#61548:firstofall,theproductioncostshavebeengreatlyimproved:theutilitieshavebeensubstantialIyimproved;forexample,apharmaceuticalcompanyinGuangxiha

11、son1yoneelectricitybi11permonth,anincreaseof10thousandyuanmorethanthatoftheoriginalnonGMPworkshop.GuangdongJiangmensomepharmaceuticalcompaniesthroughtheGMPcertification,productioncoststhantheoriginalincreaseofmorethan30%.Theincreaseinproductioncostswillmakesomeoftheprofitmarginsthatoriginallyre1icdo

12、nsalesvolumes.?managementcostsincreased:strictlyinaccordancewiththeGMPstandardmanagementoperations,makingmanagementcostssoared,butalsoalotofenterprisesoverwhelmed.?lowproductionefficiency:thecausesofthe1owefficiencyofthefollowingmainreasons:theselectionofequipment,equipmentinstallation,nowrongworker

13、shaven,tmasteredthetechnicalparametersoftheequipment,withoutlearningcurve.?newplant,equipmentoperationisnotskilled,theproductsproducedhighrateoffailure.2,tosolvetheprescriptionPrescriptionone,large-scaleproduction,improveefficiencyRapidincreaseofproductionworkersonequipmentproficiency,stopproduction

14、byagroupofcompetentgettersintheshortterm,tograsptheoperationtechnology,shortenthelearningcurveandreducethecostoflearningcurve.Onlyinthiswaycantherateofdefectiveproductsbereducedassoonaspossible,andtheadvantagesofthenewequipmentwi11bebroughtintoplay,Improvetheproductionefficiency,inthefiercemarketcom

15、petitionenvironment,largescaleproduction,andstrictlycontroleverylinkcosts,isundoubtedlytheonlypropercoursetotakeenterprisestoWinthecompetitiveadvantageoflowcost.Withthecostofrawmaterialsandvariouscostsdown,thetotalcostisautomaticallyreduced.Thesalespriceis10yuanthesameproduct,ifthecostfromtheorigina

16、l5yuandownto3yuannow,sotheenterprisecannotdevelopnewconsumers,occupynewmarket,butalsofromtheexistingmarketsharetowinmorethantheoriginalsalesprofit.Prescriptiontwo,assoonaspossibletopreventproductionoftechnicalpersonneltotacklekeyissues,shortentheproductionoflearningcurvetimeIntheprocessofproducingaproductmultipletimes,itisobservedthattheamountofresourcesneededtoproduceaunitofproductioncontinuouslydecreasesastheamountofaccumulatedoutputincreases.Thediminishingeffectofinputfactorsandrelatedc

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 论文 > 期刊/会议论文

copyright@ 2008-2023 1wenmi网站版权所有

经营许可证编号:宁ICP备2022001189号-1

本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。第壹文秘仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知第壹文秘网,我们立即给予删除!